Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 4, 2007, Pages 1566-1569

  Pérez Vázquez, María ^a   Román, Federico ^a   García Cobos, Silvia ^a   Campos, José ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; PORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GYRA GENE; GYRB GENE; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARC GENE; PARE GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; SEQUENCE ANALYSIS;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GENES, BACTERIAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION;

EID: 34247134205     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01437-06     Document Type: Article

References (25)

1. Barriere, S. L., and J. Hindler. 1993. Ciprofloxacin resistant Haemophilus influenzae in a patient with chronic lung disease. Ann. Pharmacother. 27:309-310.
2. Bastida, T., M. Perez-Vazquez, J. Campos, M. C. Cortes-Lletget, F. Roman, F. Tubau, A. G. de la Campa, and C. Alonso-Tarres. 2003. Levofloxacin treatment failure in Haemophilus influenzae pneumonia. Emerg. Infect. Dis. 9:1475-1478.
3. Blázquez, J. 2003. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin. Infect. Dis. 37:1201-1209.
4. Bootsma, H. G., A. Troelstra, A. V. Veen-Rutgers, F. R Mooi, A. J. de Neeling, and B. P. Overbeek. 1997. Isolation and characterization of a ciprofloxacin-resistant isolate of Haemophilus influenzae from The Netherlands. J. Antimicrob. Chemother. 39:292-293.
5. Campos, J., F. Román, M. Georgiou, C. García, R. Gómez-Lus, R. Cantón, H. Escobar, and F. Baquero. 1996. Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. J. Infect. Dis. 174:1345-1347.
6. Cohen, S. P., L. M. McMurry, D. C. Hooper, J. S. Wolfson, and S. B. Levy. 1989. Cross-resistance to fluoroquinolones in multiple-antibiotic- resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob. Agents Chemother. 33:1318-1325.
7. Fleischmann, R. D., M. D. Adams, O. White, R. A. Clayton, E. F. Kirkness, A. R. Kerlavage, C. J. Bult, J. F. Tomb, B. A. Dougherty, J. M. Merrick, et al. 1995. Whole-genome random sequencing and assembly of H. influenzae Rd. Science 269:449-604.
8. Georgiou, M., R. Muñoz, F. Román, R. Cantón, R. Gómez-Lus, J. Campos, and A. G. De La Campa. 1996. Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob. Agents Chemother. 40:1741-1744.
9. Giraud, A., I. Mastic, M. Radman, M. Fons, and F. Taddei. 2002. Mutator bacteria as a risk factor in treatment of infectious diseases. Antimicrob. Agents Chemother. 46:863-865.
10. Reference deleted.
11. Hansen, E. J., C. Hasemann, A. Clausell, J. D. Capra, K. Orth, C. R. Moomaw, C. A. Slaughter, J. L. Latimer, and E. Miller. 1989. Primary structure of the porin protein of Haemophilus influenzae type b determined by nucleotide sequence analysis. Infect. Immun. 57:1100-1107.
12. Hooper, D. C. 2005. Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologists. Clin. Infect. Dis. 40:1811-1817.
13. Kaczmarek, F. S., T. D. Gootz, F. Dib-Hajj, W. Shang, S. Hallowell, and M. Cronan. 2004. Genetic and molecular characterization of β-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob. Agents Chemother. 48:1630-1639.
14. Lomovskaya, O., M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V. J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
15. Martínez-Martínez, L., I. García, S. Ballesta, V. J. Benedí, S. Hernández-Allés, and A. Pascual. 1998. Energy-dependent accumulation of fluorquinolones in quinolone-resistant Klebsiella pneumoniae strains. Antimicrob. Agents Chemother. 42:1850-1852.
16. Martínez-Martínez, L., A. Pascual, M. C. Conejo, I. García, P. Joyanes, A. Doménech-Sánchez, and V. J. Benedí. 2002. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum β-lactamase production. Antimicrob. Agents Chemother. 46:3926-3932.
17. Nazir, J., C. Urban, N. Mariano, J. Burns, B. Tommasulo, C. Rosenberg, S. Segal-Maurer, and J. J. Rahal. 2004. Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology Clin. Infect. Dis. 38:1564-1569.
18. Reference deleted.
19. Pérez-Vázquez, M., F. Román, M. C. Varela, R. Cantón, and J. Campos. 2003. Activities of thirteen quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin: evidence for cross-resistance. J. Antimicrob. Chemother. 51:147-151.
20. Pérez-Vázquez, M., F. Román, B. Aracil, R. Cantón, and J. Campos. 2003. In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities. Antimicrob. Agents Chemother. 47:3539-3541.
21. Pérez-Vázquez, M., F. Román, B. Aracil, R. Cantón, and J. Campos. 2004. Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations. J. Clin. Microbiol. 42:1185.
22. Román, F., R. Cantón, M. Pérez-Vázquez, F. Baquero, and J. Campos. 2004. Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. J. Clin. Microbiol. 42:1450-1459.
23. Trong, H. N., A.-L. Prunier, and R. Leclercq. 2005. Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 49:2098-2101.
24. Watson, M. E., Jr., J. L. Burns, and A. L. Smith. 2004. Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. Microbiology 150:2947-2958.
25. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.